321 related articles for article (PubMed ID: 27812412)
1. In silico study on anti-Chikungunya virus activity of hesperetin.
Oo A; Hassandarvish P; Chin SP; Lee VS; Abu Bakar S; Zandi K
PeerJ; 2016; 4():e2602. PubMed ID: 27812412
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
[TBL] [Abstract][Full Text] [Related]
3. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
[TBL] [Abstract][Full Text] [Related]
4. In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.
Dutta SK; Sengupta S; Tripathi A
In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):255-267. PubMed ID: 35381943
[TBL] [Abstract][Full Text] [Related]
5. Development of a theoretical model for the inhibition of nsP3 protease of Chikungunya virus using pyranooxazoles.
Kumar D; Kumari K; Jayaraj A; Singh P
J Biomol Struct Dyn; 2020 Jul; 38(10):3018-3034. PubMed ID: 31366291
[TBL] [Abstract][Full Text] [Related]
6.
Kumar D; Meena MK; Kumari K; Patel R; Jayaraj A; Singh P
Heliyon; 2020 Aug; 6(8):e04720. PubMed ID: 32904235
[TBL] [Abstract][Full Text] [Related]
7. Computational approach to study the synthesis of noscapine and potential of stereoisomers against nsP3 protease of CHIKV.
Singh P; Kumar D; Vishvakarma VK; Yadav P; Jayaraj A; Kumari K
Heliyon; 2019 Dec; 5(12):e02795. PubMed ID: 32382664
[TBL] [Abstract][Full Text] [Related]
8. Drug repurposing approach against chikungunya virus: an
Kasabe B; Ahire G; Patil P; Punekar M; Davuluri KS; Kakade M; Alagarasu K; Parashar D; Cherian S
Front Cell Infect Microbiol; 2023; 13():1132538. PubMed ID: 37180434
[TBL] [Abstract][Full Text] [Related]
9. Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease.
Dhindwal S; Kesari P; Singh H; Kumar P; Tomar S
J Biomol Struct Dyn; 2017 Dec; 35(16):3522-3539. PubMed ID: 27844505
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
[TBL] [Abstract][Full Text] [Related]
11.
Chaudhary M; Sehgal D
J Biomol Struct Dyn; 2022; 40(22):11560-11570. PubMed ID: 34355667
[TBL] [Abstract][Full Text] [Related]
12. Designed thiazolidines: an arsenal for the inhibition of nsP3 of CHIKV using molecular docking and MD simulations.
Meena MK; Kumar D; Jayaraj A; Kumar A; Kumari K; Katata-Seru LM; Bahadur I; Kumar V; Sherawat A; Singh P
J Biomol Struct Dyn; 2022 Mar; 40(4):1607-1616. PubMed ID: 33073705
[TBL] [Abstract][Full Text] [Related]
13. Computational Approach Towards Exploring Potential Anti-Chikungunya Activity of Selected Flavonoids.
Seyedi SS; Shukri M; Hassandarvish P; Oo A; Shankar EM; Abubakar S; Zandi K
Sci Rep; 2016 Apr; 6():24027. PubMed ID: 27071308
[TBL] [Abstract][Full Text] [Related]
14. Chikungunya virus nsP1 interacts directly with nsP2 and modulates its ATPase activity.
Kumar S; Kumar A; Mamidi P; Tiwari A; Kumar S; Mayavannan A; Mudulli S; Singh AK; Subudhi BB; Chattopadhyay S
Sci Rep; 2018 Jan; 8(1):1045. PubMed ID: 29348627
[TBL] [Abstract][Full Text] [Related]
15. Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches.
Nguyen PT; Yu H; Keller PA
J Mol Graph Model; 2015 Apr; 57():1-8. PubMed ID: 25622129
[TBL] [Abstract][Full Text] [Related]
16. Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes.
Göertz GP; Lingemann M; Geertsema C; Abma-Henkens MHC; Vogels CBF; Koenraadt CJM; van Oers MM; Pijlman GP
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006958. PubMed ID: 30412583
[TBL] [Abstract][Full Text] [Related]
17. Mosquito Rasputin interacts with chikungunya virus nsP3 and determines the infection rate in Aedes albopictus.
Fros JJ; Geertsema C; Zouache K; Baggen J; Domeradzka N; van Leeuwen DM; Flipse J; Vlak JM; Failloux AB; Pijlman GP
Parasit Vectors; 2015 Sep; 8():464. PubMed ID: 26384002
[TBL] [Abstract][Full Text] [Related]
18. Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication.
Scholte FE; Tas A; Albulescu IC; Žusinaite E; Merits A; Snijder EJ; van Hemert MJ
J Virol; 2015 Apr; 89(8):4457-69. PubMed ID: 25653451
[TBL] [Abstract][Full Text] [Related]
19. In silico identification of chikungunya virus replication inhibitor validated using biochemical and cell-based approaches.
Chaudhary M; Kumar A; Bala Sharma K; Vrati S; Sehgal D
FEBS J; 2024 Feb; ():. PubMed ID: 38303163
[TBL] [Abstract][Full Text] [Related]
20. Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2.
Utt A; Das PK; Varjak M; Lulla V; Lulla A; Merits A
J Virol; 2015 Mar; 89(6):3145-62. PubMed ID: 25552719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
